Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
作者： Cathal J. Moran , Malcolm R. Kell , Fidelma L. Flanagan , Maria Kennedy , Thomas F. Gorey
DOI: 10.1016/J.AMJSURG.2006.11.027
关键词:
摘要: Abstract Background The role of sentinel lymph node biopsy (SLNB) for ductal carcinoma in situ (DCIS) is poorly defined. However, up to 20% patients with DCIS will have invasive carcinoma; these require staging axillary metastasis. aim this study was identify a core diagnosis who may benefit from SLNB. Methods In prospective study, we performed SLNB on preoperative >2.5 cm high-grade or when mastectomy indicated. Results Sixty-two underwent surgery DCIS, and 35 Postsurgical excision histology revealed disease 20 patients, 19 whom had undergone Before the adoption selected all occult would required second ( P Conclusions should not be routinely an initial DCIS. selective lymphadenectomy useful clinical adjuvant high-risk patients.
elsevier.com
sci-hub.se 参考文章(53)
Carol H. Lee, Darryl Carter, Liane E. Philpotts, Marta E. Couce, Laura J. Horvath, Robert C. Lange, Irena Tocino, Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology. ,vol. 217, pp. 466- 470 ,(2000) , 10.1148/RADIOLOGY.217.2.R00NV08466
Kambiz Dowlatshahi, Ming Fan, Howard C. Snider, Fahim A. Habib, Lymph Node Micrometastases from Breast Carcinoma Reviewing the Dilemma Cancer. ,vol. 80, pp. 1188- 1197 ,(1997) , 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H
Hiram S. Cody, Nancy Klauber-DeMore, Patrick I. Borgen, Kimberly J. Van Zee, Is It Really Duct Carcinoma In Situ? Annals of Surgical Oncology. ,vol. 8, pp. 617- 617 ,(2001) , 10.1007/S10434-001-0617-0
Armando E. Giuliano, Paul S. Dale, Roderick R. Turner, Donald L. Morton, Sheila W. Evans, David L. Krasne, Improved axillary staging of breast cancer with sentinel lymphadenectomy. Annals of Surgery. ,vol. 222, pp. 394- 401 ,(1995) , 10.1097/00000658-199509000-00016
RJ Cote, H Fpeterson, B Chaiwun, RD Gelber, A Goldhirsch, M Castiglione-Gertsch, B Gusterson, AM Neville, Role of immunohistochemical detection of lymph-node metastases in management of breast cancer The Lancet. ,vol. 354, pp. 896- 900 ,(1999) , 10.1016/S0140-6736(98)11104-2
László Tabár, Hsiu-Hsi Chen, Stephen W Duffy, MF Yen, CF Chiang, Peter B Dean, Robert A Smith, A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective study The Lancet. ,vol. 355, pp. 429- 433 ,(2000) , 10.1016/S0140-6736(00)82008-5
D.N. Poller, A. Barth, D.J. Slamon, M.J. Silverstein, E.D. Gierson, W.J. Coburn, J.R. Waisman, P. Gamagami, B.S. Lewinsky, Prognostic classification of breast ductal carcinoma-in-situ The Lancet. ,vol. 345, pp. 1154- 1157 ,(1995) , 10.1016/S0140-6736(95)90982-6
John J Albertini, Gary H Lyman, Charles Cox, Tim Yeatman, Ludovico Balducci, NiNi Ku, Steve Shivers, Claudia Berman, Karen Wells, David Rapaport, Alan Shons, John Horton, Harvey Greenberg, Santo Nicosia, Robert Clark, Alan Cantor, Douglas S Reintgen, Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer JAMA: The Journal of the American Medical Association. ,vol. 276, pp. 1818- 1822 ,(1996) , 10.1001/JAMA.1996.03540220042028
S. Imoto, T. Hasebe, Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Japanese Journal of Clinical Oncology. ,vol. 29, pp. 11- 15 ,(1999) , 10.1093/JJCO/29.1.11
R. T. Greenlee, T. Murray, S. Bolden, P. A. Wingo, Cancer statistics, 2000. CA: A Cancer Journal for Clinicians. ,vol. 50, pp. 7- 33 ,(2000) , 10.3322/CANJCLIN.50.1.7